PSTPIP1
Basic information
Region (hg38): 15:76993359-77037475
Links
Phenotypes
GenCC
Source:
- pyogenic arthritis-pyoderma gangrenosum-acne syndrome (Strong), mode of inheritance: AD
- pyogenic arthritis-pyoderma gangrenosum-acne syndrome (Supportive), mode of inheritance: AD
- recurrent infections-inflammatory syndrome due to zinc metabolism disorder syndrome (Supportive), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne | AD | Allergy/Immunology/Infectious; Pharmacogenomic | Medical treatment (eg, anakinra) can be effective to treat autoimmune manifestations; Cytopenia related to sulfonamide use has been reported | Allergy/Immunology/Infectious; Dermatologic; Endocrine; Musculoskeletal | 9212761; 11971877; 19673875; 21790734 |
ClinVar
This is a list of variants' phenotypes submitted to
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome (3 variants)
- not provided (2 variants)
- PSTPIP1-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSTPIP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 101 | 110 | ||||
missense | 211 | 22 | 237 | |||
nonsense | 13 | |||||
start loss | 0 | |||||
frameshift | 10 | 10 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 16 | 28 | 3 | 47 | ||
non coding | 17 | 113 | 53 | 183 | ||
Total | 3 | 0 | 258 | 240 | 57 |
Variants in PSTPIP1
This is a list of pathogenic ClinVar variants found in the PSTPIP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-76994821-C-T | PSTPIP1-related disorder | Likely benign (Jul 15, 2019) | ||
15-76994970-C-T | Likely benign (Oct 24, 2018) | |||
15-76995138-G-A | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Benign (Jan 12, 2018) | ||
15-76995149-G-GCTGC | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome • Autoinflammatory syndrome | Benign/Likely benign (Aug 21, 2019) | ||
15-76995149-G-GCTGCCTGCCTGC | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Benign (Aug 21, 2019) | ||
15-76995207-G-A | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Uncertain significance (Jan 13, 2018) | ||
15-76995291-G-GGGGCT | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Uncertain significance (Jun 14, 2016) | ||
15-76995399-C-G | PSTPIP1-related disorder | Uncertain significance (Apr 10, 2024) | ||
15-76995403-A-T | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Benign (Jan 13, 2018) | ||
15-76995415-C-G | PSTPIP1-related disorder | Likely benign (Feb 19, 2019) | ||
15-76995433-C-T | PSTPIP1-related disorder | Likely benign (Feb 19, 2019) | ||
15-76995436-A-T | Benign (Mar 03, 2015) | |||
15-76995448-G-T | PSTPIP1-related disorder | Likely benign (May 06, 2021) | ||
15-76995450-C-T | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Benign/Likely benign (Feb 02, 2019) | ||
15-76995451-G-A | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Likely benign (Mar 23, 2020) | ||
15-76995454-G-A | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Likely benign (Sep 03, 2021) | ||
15-76995457-C-T | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome • PSTPIP1-related disorder | Benign (Jan 13, 2018) | ||
15-76995558-C-T | not specified | Likely benign (Jun 23, 2017) | ||
15-76995573-G-A | PSTPIP1-related disorder | Likely benign (May 04, 2022) | ||
15-76995578-T-C | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome • Autoinflammatory syndrome | Conflicting classifications of pathogenicity (Dec 21, 2023) | ||
15-76995579-G-T | Inborn genetic diseases | Uncertain significance (Jul 25, 2023) | ||
15-76995580-C-T | Uncertain significance (Jul 01, 2016) | |||
15-76995588-G-A | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Likely benign (Jul 07, 2023) | ||
15-76995590-A-G | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Uncertain significance (May 08, 2022) | ||
15-76995590-A-T | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | Uncertain significance (Sep 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSTPIP1 | protein_coding | protein_coding | ENST00000558012 | 15 | 43974 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000246 | 0.996 | 124457 | 1 | 79 | 124537 | 0.000321 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.917 | 215 | 256 | 0.839 | 0.0000167 | 2652 |
Missense in Polyphen | 48 | 65.336 | 0.73467 | 631 | ||
Synonymous | -0.931 | 121 | 109 | 1.11 | 0.00000770 | 760 |
Loss of Function | 2.55 | 14 | 28.8 | 0.487 | 0.00000141 | 309 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000355 | 0.000354 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000111 |
Finnish | 0.000149 | 0.000139 |
European (Non-Finnish) | 0.000175 | 0.000168 |
Middle Eastern | 0.000112 | 0.000111 |
South Asian | 0.00152 | 0.00147 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in regulation of the actin cytoskeleton. May regulate WAS actin-bundling activity. Bridges the interaction between ABL1 and PTPN18 leading to ABL1 dephosphorylation. May play a role as a scaffold protein between PTPN12 and WAS and allow PTPN12 to dephosphorylate WAS. Has the potential to physically couple CD2 and CD2AP to WAS. Acts downstream of CD2 and CD2AP to recruit WAS to the T-cell:APC contact site so as to promote the actin polymerization required for synapse induction during T-cell activation (By similarity). Down-regulates CD2-stimulated adhesion through the coupling of PTPN12 to CD2. Also has a role in innate immunity and the inflammatory response. Recruited to inflammasomes by MEFV. Induces formation of pyroptosomes, large supramolecular structures composed of oligomerized PYCARD dimers which form prior to inflammatory apoptosis. Binding to MEFV allows MEFV to bind to PYCARD and facilitates pyroptosome formation. Regulates endocytosis and cell migration in neutrophils. {ECO:0000250, ECO:0000269|PubMed:17964261, ECO:0000269|PubMed:18480402, ECO:0000269|PubMed:19109554, ECO:0000269|PubMed:19584923, ECO:0000269|PubMed:9857189}.;
- Disease
- DISEASE: PAPA syndrome (PAPAS) [MIM:604416]: Characterized by autosomal dominant inheritance of early-onset, primarily affecting skin and joint tissues. Recurring inflammatory episodes lead to accumulation of sterile, pyogenic, neutrophil-rich material within the affected joints, ultimately resulting in significant destruction. {ECO:0000269|PubMed:11971877, ECO:0000269|PubMed:14595024, ECO:0000269|PubMed:22161697}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);T-Cell antigen Receptor (TCR) Signaling Pathway;The NLRP3 inflammasome;Inflammasomes;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;TCR;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- 0.794
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.71
Haploinsufficiency Scores
- pHI
- 0.189
- hipred
- Y
- hipred_score
- 0.669
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.671
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pstpip1
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- endocytosis;inflammatory response;cell adhesion;signal transduction;actin filament polymerization;innate immune response
- Cellular component
- uropod;cytoplasm;cytosol;cytoskeleton;actin filament;plasma membrane;membrane;lamellipodium;cleavage furrow;perinuclear region of cytoplasm
- Molecular function
- protein binding;cytoskeletal protein binding;identical protein binding;actin filament binding